Eyenovia EYEN

$ 0.11 0.19%

Quarterly report 2024-Q3
added 11-12-2024

Eyenovia Balance Sheet 2011-2024 | EYEN

Annual Balance Sheet Eyenovia

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-13.1 M	-21.5 M	-	-27.9 M	-14.1 M	-19.7 M	-5.25 M	-3.39 M	-2.49 M	-	-	-	-
Long Term Debt	1.29 M	908 K	-	366 K	-	-	-	-	-	-	-	-	-
Long Term Debt Current	501 K	485 K	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	404 K	45.4 K	41.6 K	-	-	-	-	-	-	-
Total Current Liabilities	9.53 M	4.51 M	11.2 M	18.2 M	2.91 M	3.1 M	553 K	-	-	-	-	-	-
Total Liabilities	19.8 M	13.8 M	11.2 M	18.6 M	2.96 M	3.14 M	553 K	424 K	420 K	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-145 M	-118 M	-90.2 M	-77.4 M	-57.7 M	-36.5 M	-19.3 M	-14.1 M	-10.6 M	-	-	-	-
Total Assets	28.8 M	31 M	31.7 M	33.9 M	14.7 M	20 M	5.64 M	3.43 M	2.82 M	-	-	-	-
Cash and Cash Equivalents	14.8 M	22.9 M	19.5 M	28.4 M	14.2 M	19.7 M	5.25 M	3.39 M	-	-	-	-	-
Book Value	9 M	17.2 M	20.5 M	15.3 M	11.7 M	16.9 M	5.09 M	3.01 M	2.4 M	-	-	-	-
Total Shareholders Equity	9 M	17.2 M	20.5 M	15.3 M	11.7 M	16.9 M	5.09 M	3.01 M	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Eyenovia

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	836 K	984 K	1.14 M	1.29 M	1.44 M	1.58 M	1.13 M	908 K	-	-	-	-	-	7.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	19.1 M	21.4 M	24.4 M	19.8 M	19.1 M	18.8 M	13.5 M	13.8 M	11.1 M	12 M	10.4 M	11.2 M	20.7 M	21.6 M	16.7 M	18.6 M	18.6 M	18.6 M	18.6 M	2.96 M	2.96 M	2.96 M	2.96 M	3.14 M	3.14 M	3.14 M	3.14 M	553 K	553 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	10 M	10 M	12 M	14 M	14 M	14 M	14 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-175 M	-167 M	-156 M	-145 M	-138 M	-130 M	-124 M	-118 M	-112 M	-105 M	-97.6 M	-90.2 M	-93.2 M	-87.6 M	-82.8 M	-77.4 M	-77.4 M	-77.4 M	-77.4 M	-57.7 M	-57.7 M	-57.7 M	-57.7 M	-36.5 M	-36.5 M	-36.5 M	-36.5 M	-19.3 M	-19.3 M	-19.3 M	-19.3 M	-14.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	22.8 M	19 M	26.2 M	28.8 M	34.9 M	29.3 M	29.3 M	31 M	31.4 M	35.6 M	40.2 M	31.7 M	25 M	30.6 M	28.9 M	33.9 M	33.9 M	33.9 M	33.9 M	14.7 M	14.7 M	14.7 M	14.7 M	20 M	20 M	20 M	20 M	5.64 M	5.64 M	5.64 M	5.64 M	3.43 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	7.19 M	2.3 M	7.98 M	14.8 M	20.7 M	17.5 M	18.5 M	22.9 M	17.4 M	21.5 M	26.7 M	19.5 M	13.5 M	27.2 M	24.9 M	28.4 M	28.4 M	28.4 M	28.4 M	14.2 M	14.2 M	14.2 M	14.2 M	19.7 M	19.7 M	19.7 M	19.7 M	5.25 M	5.25 M	5.25 M	5.25 M	3.39 M	-	-	-	2.49 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	3.72 M	-2.37 M	1.82 M	9 M	15.8 M	10.5 M	15.8 M	17.2 M	20.3 M	23.6 M	29.8 M	20.5 M	4.25 M	8.99 M	12.1 M	15.3 M	15.3 M	15.3 M	15.3 M	11.7 M	11.7 M	11.7 M	11.7 M	16.9 M	16.9 M	16.9 M	16.9 M	5.09 M	5.09 M	5.64 M	5.64 M	3.43 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	3.72 M	-2.37 M	1.82 M	9 M	15.8 M	10.5 M	15.8 M	17.2 M	20.3 M	23.6 M	29.8 M	20.5 M	4.25 M	8.99 M	12.1 M	15.3 M	15.3 M	15.3 M	15.3 M	11.7 M	11.7 M	11.7 M	11.7 M	16.9 M	16.9 M	16.9 M	16.9 M	5.09 M	5.09 M	5.09 M	5.09 M	3.01 M	-	-	-	2.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency